If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Sep 2021 17:18

RNS Number : 5143M
Circassia Group Plc
21 September 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJVD3B28

Issuer Name

CIRCASSIA GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Harwood Capital Management (Gibraltar) Limited

City of registered office (if applicable)

Gibraltar

Country of registered office (if applicable)

Gibraltar

Name

City of registered office

Country of registered office

Harwood Capital LLP

London

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

North Atlantic Smaller Companies Investment Trust Plc

London

United Kingdom

Harwood Capital LLP

London

United Kingdom

Oryx International Growth Fund Limited

Guernsey

Guernsey

5. Date on which the threshold was crossed or reached

17-Sep-2021

6. Date on which Issuer notified

21-Sep-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

18.55

0.00

18.55

77,595,000

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BJVD3B28

40,000,000

9.56

GB00BJVD3B28

595,000

0.14

GB00BJVD3B28

37,000,000

8.85

Sub Total 8.A

77,595,000

18.55%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Christopher Harwood Bernard Mills

Oryx International Growth Fund Limited

9.56

Christopher Harwood Bernard Mills

Harwood Capital LLP

0.14

Christopher Harwood Bernard Mills

North Atlantic Smaller Companies Investment Trust Plc

8.85

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

21-Sep-2021

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLLBMFTMTBTBFB
Date   Source Headline
27th Jan 202011:47 amRNSHolding(s) in Company
21st Jan 20201:46 pmRNSHolding(s) in Company
17th Jan 20203:34 pmRNSHolding(s) in Company
15th Jan 20202:22 pmRNSHolding(s) in Company
13th Jan 20203:13 pmRNSHolding(s) in Company
10th Jan 20205:39 pmRNSHolding(s) in Company
10th Jan 20205:38 pmRNSHolding(s) in Company
10th Jan 20203:18 pmRNSInvestment in Circassia Pharmaceuticals plc
9th Jan 20204:26 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNSCircassia Announces Business Update
3rd Jan 202011:53 amRNSHolding(s) in Company
31st Dec 20197:00 amRNSTotal Voting Rights
19th Dec 20192:03 pmRNSGrant of Options
19th Dec 20197:04 amRNSUpdate on Licensing Agreement with BeyondAir Inc.
17th Dec 201910:50 amRNSHolding(s) in Company
13th Dec 20194:05 pmRNSHolding(s) in Company
6th Dec 201912:25 pmRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSCircassia Announces Board Changes
3rd Dec 20194:33 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSTotal Voting Rights Update
27th Nov 20191:38 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSHolding(s) in Company
26th Nov 20194:55 pmRNSHolding(s) in Company
26th Nov 20194:51 pmRNSHolding(s) in Company
25th Nov 20195:38 pmRNSHolding(s) in Company
25th Nov 20195:35 pmRNSHolding(s) in Company
4th Nov 20192:48 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights Update
21st Oct 20197:00 amRNSUS launch of Duaklir at CHEST 2019
17th Oct 20195:34 pmRNSGrant of options
4th Oct 20194:30 pmRNSHolding(s) in Company
1st Oct 201911:25 amRNSDirector/PDMR Shareholding
30th Sep 201911:06 amRNSTotal Voting Rights
30th Sep 201911:02 amRNSBlock listing Interim Review
26th Sep 20197:00 amRNSInterim Results for Six Months Ended 30 June 2019
20th Sep 20193:37 pmRNSHolding(s) in Company
19th Sep 20195:40 pmRNSHolding(s) in Company
18th Sep 20195:26 pmRNSHolding(s) in Company
18th Sep 20195:21 pmRNSHolding(s) in Company
17th Sep 20191:10 pmRNSHolding(s) in Company
17th Sep 201912:01 pmRNSHolding(s) in Company
16th Sep 20194:51 pmRNSHolding(s) in Company
13th Sep 20195:57 pmRNSBlock listing Interim Review
12th Sep 20197:00 amRNSNotice of Results and Appointment of Joint Broker
30th Aug 20197:00 amRNSTotal Voting Rights
23rd Aug 20195:23 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSAppointment of Jonathan Emms as COO
31st Jul 20191:55 pmRNSTotal Voting Rights
22nd Jul 20194:12 pmRNSHolding(s) in Company
9th Jul 20191:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.